Pedro Manuel Reis Pereira

Dr. Pedro Manuel Reis Pereira


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Transplantation Proceedings
Verified
Journal Article
Closed access
RVRita Veríssimo
Rita Veríssimo
MAManuela Barbosa Almeida
Manuela Barbosa Almeida
JOJoão Pedro Oliveira
João Pedro Oliveira
PPPedro Manuel Reis Pereira
Pedro Manuel Reis Pereira
BRBárbara O. Ribeiro
Bárbara O. Ribeiro
LDLeonidio Dias
Leonidio Dias

5 December 2024 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
PPPedro Manuel Reis Pereira
Pedro Manuel Reis Pereira
MAManuela Barbosa Almeida
Manuela Barbosa Almeida
Patricia Crespo BragaPatricia Crespo Braga
Patricia Crespo Braga
JPJoão Pereira
João Pereira
SPSofia S. Pereira
Sofia S. Pereira
ARAnabela Rodrigues
Anabela Rodrigues
Background: Obesity has a negative impact in kidney health. However, the hallmarks of kidney dysfunction in bariatric surgery candidates are poorly characterized. To address this knowledge gap, we used a propensity score-matched analysis to compare kidney lesion biomarkers in bariatric surgery candidates and living kidney donors. Methods: Bariatric surgery candidates attending a single center for obesity treatment were pair-matched for sex and age to potential living kidney transplant donors (PLKD) using a 1:1 nearest-neighbor approach (N = 400, n = 200/group). A 24-h urine collection was used to analyze proteinuria and creatinine clearance. Results: Patients with obesity (PWO) had higher creatinine clearance when compared to PLKD (143.35 ± 45.50 mL/min vs 133.99 ± 39.06 mL/min, p = 0.03), which was underestimated when correction for body surface area (BSA) was used (creatinine clearance corrected for BSA of 115.25 ± 33.63 mL/min/1.73 m2 in PWO vs 135.47 ± 35.56 mL/min/1.73 m2 in PLKD). Proteinuria was also higher in PWO compared to PLKD (139.82 ± 353.258 mg/day vs 136.35 ± 62.24 mg/day, p < 0.0001). Regression analysis showed that creatinine clearance was strongly correlated with proteinuria in PWO (HR 1.522, p = 0.005), but it was less evident in PLKD (HR 0.376, p = 0.001). Conclusion: Hyperfiltration and disproportionate proteinuria are frequent in patients with obesity. Since hyperfiltration can be underestimated by adjusting creatinine clearance for BSA, this should not be used when evaluating kidney function in bariatric surgery candidates.

10 October 2022 in Cureus
Verified
Journal Article
Open access
PPPedro Manuel Reis Pereira
Pedro Manuel Reis Pereira
MAManuela Barbosa Almeida
Manuela Barbosa Almeida
BRBárbara Ribeiro
Bárbara Ribeiro
JOJoão Oliveira
João Oliveira
LCLuisa Costa
Luisa Costa
JMJorge Malheiro
Jorge Malheiro
Introduction: Kidney transplantation (KT) from living donors has been shown to have multiple benefits compared to those from deceased donors. We sought to compare significant graft outcomes, namely acute rejection (AR), graft function, and survival between transplant recipients who received a kidney from living related donor (LRD) and living unrelated donor (LURD). Methods: Our cohort comprised 198 donor and recipient pairs undergoing living-donor KT at our center over 10 years. The LRD recipients were compared with LURD recipients according to demographic and clinical characteristics, transplant variables (including immunosuppression), graft function, survival, and AR rate. Results: The estimated glomerular filtration rate (eGFR) was similar in both groups over the follow-up time i.e., 60-65 mL/min (p>0.05 over 10 years). Censored graft survival was similar between LRD and LURD recipients (96.9% vs. 98.0% at five years and 87.8% vs. 79.4% at 10 years, respectively; p=0.837). The LURD recipients had a higher incidence of AR, although LURD recipient status was not an independent risk factor for AR. Multivariate analysis showed that human leukocyte antigen (HLA)-DR mismatch (MM) was an independent predictor of AR (hazard ratio (HR) 2.256, p<0.05). Both HLA-A and HLA-B MM did not affect the AR HR between the groups. Conclusion: Graft function and censored graft survival rates were similar between LURD and LRD KT recipients in our study. The AR was higher in LURD recipients, although the LURD recipient status was not an independent risk factor for AR. The HLA-DR MM was an independent predictor of AR, while HLA-A and HLA-B MM did not affect AR HR between groups of patients.

13 October 2022 in Cureus
Verified
Journal Article
Open access
PPPedro Manuel Reis Pereira
Pedro Manuel Reis Pereira
BRBárbara Ribeiro
Bárbara Ribeiro
JOJoão Oliveira
João Oliveira
SSSofia Santos
Sofia Santos
SPSofía Pedroso
Sofía Pedroso
JMJorge Malheiro
Jorge Malheiro
Limited information exists concerning the clinical significance of histologically confirmed antibody-mediated rejection (h-AMR) without detectable circulating donor-specific antibodies (DSA). In this study, we compared the outcomes of patients with h-AMR according to DSA status. A total of 80 kidney transplant (KT) recipients who met the 2018 Banff criteria for h-AMR were included. Clinical and immunological characteristics were evaluated, and outcomes were compared according to DSA status after kidney biopsy (KB). There were 57 patients who had DSA-positive (+) h-AMR and 23 patients who had DSA-negative (-) h-AMR. Groups had similar baseline characteristics and time between KT and KB. Concerning histopathological diagnoses/Banff scores, DSA+ patients had higher interstitial fibrosis (ci) and tubular atrophy (ct) (ci+ct) scores and lower arterial hyalinosis (ah) scores compared to DSA- patients. Graft survival (GS) was similar for both groups (64% versus 44% at five years and 44% versus 34% at 10 years). Multivariate analysis revealed the time of KB (less than six months after KT or more than six months after KT) to be associated with GS. A stratified analysis was conducted, targeting DSA status according to the time of biopsy. For KB performed less than six months after KT, GS was higher for DSA+ patients at 10 years (66% versus 23%). For KB performed more than six months after KT, DSA- patients had higher GS at 10 years (58% versus 9%). Both the timing of AMR diagnosis and DSA status had an impact on AMR outcomes. For patients diagnosed with AMR more than six months after transplantation, GS was worst for those in which circulating DSA were identified. Biopsy specimens from DSA- specimens had higher ct-ci and ah scores.